![Biomedicines | Free Full-Text | SARS-CoV-2 Gut-Targeted Epitopes: Sequence Similarity and Cross-Reactivity Join Together for Molecular Mimicry Biomedicines | Free Full-Text | SARS-CoV-2 Gut-Targeted Epitopes: Sequence Similarity and Cross-Reactivity Join Together for Molecular Mimicry](https://pub.mdpi-res.com/biomedicines/biomedicines-11-01937/article_deploy/html/images/biomedicines-11-01937-g002.png?1688738662)
Biomedicines | Free Full-Text | SARS-CoV-2 Gut-Targeted Epitopes: Sequence Similarity and Cross-Reactivity Join Together for Molecular Mimicry
![Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121001567-fx1.jpg)
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect
![The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00809-x/MediaObjects/41577_2022_809_Fig1_HTML.png)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
![Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1367593113002317-gr1.jpg)
Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect
![Frontiers | The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer Frontiers | The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer](https://www.frontiersin.org/files/Articles/1212546/fimmu-14-1212546-HTML-r2/image_m/fimmu-14-1212546-g001.jpg)
Frontiers | The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer
![Analysis of allelic cross-reactivity of monoclonal IgG antibodies by a multiplexed reverse FluoroSpot assay | eLife Analysis of allelic cross-reactivity of monoclonal IgG antibodies by a multiplexed reverse FluoroSpot assay | eLife](https://iiif.elifesciences.org/lax/79245%2Felife-79245-fig1-v1.tif/full/1500,/0/default.jpg)
Analysis of allelic cross-reactivity of monoclonal IgG antibodies by a multiplexed reverse FluoroSpot assay | eLife
![A hypothesis of immunological cross-reactivity implicating homologous... | Download Scientific Diagram A hypothesis of immunological cross-reactivity implicating homologous... | Download Scientific Diagram](https://www.researchgate.net/publication/359084894/figure/fig4/AS:11431281120118146@1676382521691/A-hypothesis-of-immunological-cross-reactivity-implicating-homologous-SARS-CoV-2-and.jpg)
A hypothesis of immunological cross-reactivity implicating homologous... | Download Scientific Diagram
![Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles: Cell Reports Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles: Cell Reports](https://www.cell.com/cms/asset/332b9640-a6ba-4262-a3c3-3ffe70c3d39a/fx1.jpg)
Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles: Cell Reports
![Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/03/18/2020.03.17.995738/F1.large.jpg)
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
![Production of monoclonal antibody against tylosin and tilmicosin with homogeneous cross-reactivity and its application in lateral flow immunoassay | Microchimica Acta Production of monoclonal antibody against tylosin and tilmicosin with homogeneous cross-reactivity and its application in lateral flow immunoassay | Microchimica Acta](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00604-023-06132-z/MediaObjects/604_2023_6132_Figa_HTML.png)
Production of monoclonal antibody against tylosin and tilmicosin with homogeneous cross-reactivity and its application in lateral flow immunoassay | Microchimica Acta
![Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses - ScienceDirect Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379120302445-fx1.jpg)